Table 3.
Association of Race-Gender Groups with Time until LDL Cholesterol Control in Cox Proportional Hazards Models Adjusted for Sequentially Added Sets of Variables
| Variables Added to Model | ||||||
|---|---|---|---|---|---|---|
| Unadjusted |
Socio- demographic |
Clinical Comorbidities |
Health Care | Primary Care Provider | LDL Management | |
| Hazard Ratio [95% CI] | ||||||
| Race-gender Group | ||||||
| Black Women | 0.61 [0.53-0.69]‡ |
0.65 [0.56-0.76]‡ |
0.63 [0.54-0.74]‡ |
0.64 [0.54-0.75]‡ |
0.63 [0.53-0.74]‡ |
0.66 [0.56-0.78]‡ |
| Black Men | 0.75 [0.64-0.86]‡ |
0.78 [0.66-0.93]† |
0.77 [0.65-0.91]† |
0.79 [0.66-0.94]† |
0.73 [0.63-0.86]† |
0.82 [0.69-0.98]* |
| White Women | 0.72 [0.62-0.83]‡ |
0.75 [0.64-0.87]‡ |
0.74 [0.64-0.86]‡ |
0.75 [0.64-0.87]‡ |
0.78 [0.65-0.93]‡ |
0.75 [0.64-0.88]† |
| White Men | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
*P < 0.05
† P ≤ 0.01
‡ P ≤ 0.001
Demographics [i.e., age, neighborhood income]; clinical comorbidities [i.e., vascular disease, diabetes, renal insufficiency, unrelated comorbidities, smoking]; health care [i.e., insurance, number of annual visits; visit adherence; antihypertensive medications]; primary care provider [i.e. type, race, gender, workload]; LDL management [i.e., baseline LDL, LDL checks within 6 months, and lipid-lowering drug potency].